Primary Chemoablation Of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Using Ugn-102, A Mitomycin-Containing Reverse Thermal Gel (Optima Ii): A Phase 2b, Open-Label, Single-Arm Trial

Nonsurgical primary chemoablation of LG IR NMIBC using UGN-102 resulted in significant treatment response with sustained durability. UGN-102 may provide an alternative to repetitive surgery for patients with LG IR NMIBC.